Glenmark Pharmaceuticals Ltd is quoting at Rs 414.75, down 1.27% on the day as on 13:19 IST on the NSE. The stock tumbled 16.25% in last one year as compared to a 0.89% slide in NIFTY and a 8.05% fall in the Nifty Metal index.
Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 414.75, down 1.27% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.32% on the day, quoting at 17951.35. The Sensex is at 60319.53, up 0.38%.Glenmark Pharmaceuticals Ltd has eased around 0.48% in last one month.Meanwhile, Nifty Metal index of which Glenmark Pharmaceuticals Ltd is a constituent, has eased around 0.41% in last one month and is currently quoting at 12659.4, down 0.51% on the day. The volume in the stock stood at 1.53 lakh shares today, compared to the daily average of 10.83 lakh shares in last one month.
The benchmark January futures contract for the stock is quoting at Rs 414.95, down 1.33% on the day. Glenmark Pharmaceuticals Ltd tumbled 16.25% in last one year as compared to a 0.89% slide in NIFTY and a 8.05% fall in the Nifty Metal index.
The PE of the stock is 7.1 based on TTM earnings ending September 22.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app